Slavica Pavlov-Dolijanovic

Prof. Slavica Pavlov-Dolijanovic

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in Medicina
Verified
Journal Article
Open access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
MBMilan Bogojevic
Milan Bogojevic
TRTatjana Nozica Radulovic
Tatjana Nozica Radulovic
Goran RadunovicGoran Radunovic
Goran Radunovic
NMNatasa Mujovic
Natasa Mujovic
Elderly-onset rheumatoid arthritis (EORA) is a distinct clinical entity defined as the onset of rheumatoid arthritis (RA) in individuals aged over 60 years. EORA presents unique clinical features, including a more equitable distribution of sexes, a potential predilection for male involvement, a higher incidence of acute onset characterized by constitutional symptoms, a propensity for systemic manifestations, elevated sedimentation rates at disease onset, a reduced occurrence of rheumatoid factor positivity, increased titers of anti-citrullinated protein antibodies, a preference for involvement of large joints, elevated disease activity, the presence of bone erosions, and heightened patient disability. RA is recognized to consist of three partially overlapping subsets. One subset mirrors the classical RA clinical presentation, while the remaining subsets exhibit either a polymyalgia rheumatica-like phenotype or present with remitting seronegative symmetrical synovitis accompanied by pitting edema syndrome. In the initial stages of EORA management, non-steroidal anti-inflammatory drugs (NSAIDs) are not typically the first-line treatment choice, because seniors are much more prone to develop side effects due to NSAIDs, and the use of NSAIDs is in reality contraindicated to the majority of seniors due to comorbidities. Disease-modifying antirheumatic drugs (DMARDs), frequently methotrexate, are introduced immediately after the diagnosis is made. In cases where elderly patients demonstrate resistance to conventional DMARD therapy, the introduction of biological or targeted synthetic DMARDs becomes a viable treatment option. EORA presents a unique clinical profile, necessitating tailored treatment strategies. Our study emphasizes the challenges of NSAID use in seniors, highlighting the imperative shift toward DMARDs such as methotrexate. Future research should explore personalized DMARD approaches based on disease activity, comorbidities, and safety considerations, aiming to optimize treatment outcomes and minimize glucocorticoid reliance, thereby enhancing the quality of care for EORA patients.

8 September 2011 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
NDNemanja S. Damjanov
Nemanja S. Damjanov
RSRoksanda M. Stojanovic
Roksanda M. Stojanovic
NSNada Z. Vujasinovic Stupar
Nada Z. Vujasinovic Stupar
DSDejana M. Stanisavljevic
Dejana M. Stanisavljevic

22 May 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
NDNemanja S. Damjanov
Nemanja S. Damjanov
NSNada Z. Vujasinovic Stupar
Nada Z. Vujasinovic Stupar
DMDanijel R. Marcetic
Danijel R. Marcetic
MSMirjana N. Sefik-Bukilica
Mirjana N. Sefik-Bukilica
RPRadmila R. Petrovic
Radmila R. Petrovic

2 May 2017 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
NSNada Vujasinovic Stupar
Nada Vujasinovic Stupar

11 August 2013 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
NDNemanja S. Damjanov
Nemanja S. Damjanov
NSNada Z. Vujasinovic Stupar
Nada Z. Vujasinovic Stupar
SBSnezana Baltic
Snezana Baltic
DBDragan D. Babic
Dragan D. Babic

22 July 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SPSlavica Pavlov-Dolijanovic
Slavica Pavlov-Dolijanovic
NDNemanja S. Damjanov
Nemanja S. Damjanov
NSNada Z. Vujasinovic Stupar
Nada Z. Vujasinovic Stupar
GRGoran L. Radunovic
Goran L. Radunovic
RSRoksanda M. Stojanovic
Roksanda M. Stojanovic
DBDragan Babic
Dragan Babic